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Abstract
Background: National malaria control programmes and international agencies are keen to scale-up the use of
effective rapid diagnostic tests (RDTs) for malaria. The high proportion of the Ugandan population seeking care at
drug shops makes these outlets attractive as providers of malaria RDTs. However, there is no precedent for blood
testing at drug shops and little is known about how such tests might be perceived and used. Understanding use
of drug shops by communities in Uganda is essential to inform the design of interventions to introduce RDTs.
Methods: We conducted a qualitative study, with 10 community focus group discussions, and 18 in-depth
interviews with drug shop attendants, health workers and district health officials. The formative study was carried
out in Mukono district, central Uganda an area of high malaria endemicity from May-July 2009.
Results: Drug shops were perceived by the community as important in treating malaria and there was awareness
among most drug sellers and the community that not all febrile illnesses were malaria. The idea of introducing
RDTs for malaria diagnosis in drug shops was attractive to most respondents. It was anticipated that RDTs would
improve access to effective treatment of malaria, offset high costs associated with poor treatment, and avoid
irrational drug use. However, communities did express fear that drug shops would overprice RDTs, raising the
overall treatment cost for malaria. Other fears included poor adherence to the RDT result, reuse of RDTs leading to
infections and fear that RDTs would be used to test for human immune deficiency virus (HIV). All drug shops
visited had no record on patient data and referral of cases to health units was noted to be poor.
Conclusion: These results not only provide useful lessons for implementing the intervention study but have wide
implications for scaling up malaria treatment in drug shops.
Background
In Uganda, malaria is highly endemic and the leading
cause of morbidity and mortality [1]. Effective case man-
agement of malaria is recommended as one of the inter-
ventions to control malaria. However, this is limited by
inadequate diagnostic facilities. Thus the syndromic
approach is the commonest form for diagnosing malaria
and other infectious diseases in Uganda [2-4].
The dilemma of malaria diagnosis and treatment has
been well described in Uganda and Tanzania [4]. It has
been shown that more than 90% of malaria patients
who are negative for malaria were prescribed anti-malar-
ial drugs. Based on this and other findings, it has been
concluded that there is over diagnosis of malaria among
patients presenting with febrile illnesses [5,6].
Self-treatment is the commonest form of treatment in
rural areas of Africa [7]. A recent study in Uganda
found out that 67% of children aged less than 5 years
suffered from malaria and that 38.3% of households
sought care from drug shops for sick children [8]. It was
further shown that people valued laboratory investiga-
tions commonly referred to as okukebela omusaayi.
Health facilities with laboratory facilities were visited
when self-treatment had failed and people were in
search for the cause of fever and effective treatment [8].
There are various reasons why people choose to use
pharmacies and drug shops. First, is the ease of purchas-
ing drugs and obtaining “immediate” treatment. In a
study in Togo, it was found that immediate attention
for both consultation and treatment was the single most
important reason for patronizing retail pharmacies
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any medium, provided the original work is properly cited.rather than health clinics [9]. Another important factor
was “availability of drugs at all times,” since the phar-
macy was open during hours when the health clinics
were closed.
Nevertheless, self-treatment of malaria is associated
with many potential dangers. First, self-treatment may
result in delays in taking patients with severe malaria to
health centers [10]; secondly, there is the risk of over-
treatment and overdosing which may lead death while
under treatment may lead to drug resistance [11-14].
The current practice of presumptive treatment of any feb-
rile illness as malaria in Uganda results in significant over-
use of anti-malarial drugs. However, with ACTs being a
more costly regimen, it is important to be more restrictive
whilst ensuring access to those who need anti-malarial
drugs. RDTs provide a simple means of confirming malaria
diagnosis in remote locations lacking electricity and quali-
fied health staff. However, there is no precedent for blood
testing at drug shops and little is known about how such
tests might be perceived and used. An understanding of the
current situation of drug shop attendants and the use of
shops by communities in Uganda is essential to inform the
design of interventions to introduce RDTs.
We present data from a formative study that assessed
the feasibility of introducing RDTs in drug shops in
Mukono district, central Uganda. This formative research
is nested within a wider intervention study that will intro-
duce RDTs into drug shops in a randomized controlled
trial that will assess the impact of RDTs in drug shops on
effective malaria treatment and rational anti-malarial drug
use as well as cost-effectiveness of this intervention.
Methods
Study area and population
The study was conducted in Mukono district, central
Uganda. The total population of the district is 850,900
and the majority, 88% live in the rural areas. The district
has an annual population growth rate of 2.3% per
annum and is inhabited by the Baganda an indigenous
ethnic group whose main occupation is subsistence agri-
culture [15]. The district was selected to implement the
study because it is hyper-endemic for malaria [16].
Study design
The study design was qualitative and collected data
through focus group discussions (FGDs) and in-depth
interviews (IDIs). Ten FGDs were conducted as follows:
four female groups, three male groups and three com-
munity leader groups. Each FGD comprised of 6-12 par-
ticipants. A total of 18 in-depth interviews were
conducted with nine drug shop attendants, five health
workers and four district health officials (Table 1). The
FGDs and IDIs explored the following areas: experiences
with diagnosis and treatment of malaria, affordability of
malaria treatment and RDTs, quality of care at drug
shops and payments for services at drug shops.
Participants for the FGDs and IDIs were selected with
the help of local council officials who were instrumental
in introducing interviewers to the communities. The
inclusion criteria were respondents in the reproductive
age group with children aged < 5years and consent to
participate in the study. The exclusion criterion was
refusal to participate in the study.
FGDs and IDIs were conducted by two female and
two male research assistants who are social scientists
with experience in conducting qualitative research. All
participants spoke Luganda, the local dialect, and under-
went training specifically in data collection methods and
tools to be used. The study tools were piloted and
revised. FGDs and IDIs were tape-recorded with permis-
sion from the participants. The study was conducted
between May-July 2009.
Data analyses
Data were transcribed and transferred to NVivo version
8 (QSR International). Coding of the transcripts took
place through an iterative process to generate a ‘node
tree’ of ideas represented in the data that were grouped
into themes. The themes were initially drawn from the
idea codes.
Ethical issues
The study was approved by the Uganda National Coun-
cil of Science and Technology Reference: HS 546. Verbal
consent was obtained from all participants who partici-
pated in the study.
Results
Role of drug shops
Community members, health workers and the district
health officials acknowledged the importance of drug
shops play in providing health care. Our study focused
on registered drug shops and respondents did distin-
guish these from non-registered shops, which were per-
ceived to be numerous and to provide a poorer quality
of care. The typical interaction described at registered
drug shops was as follows:
’Before you get the drug the one working there first asks
you what the problem is before getting the drugs and then
gives you the drugs basing on the money you have’ (Parti-
cipant 3, FGD with community leaders at community 9).
Current diagnosis and treatment practices
The most common methods of malaria diagnosis to
occur at registered drug shops were syndromic and
trial-and-error approaches. Occasionally, community
members and drug sellers reported that drug shops in
the study area used thermometers.
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temperature was measured using a thermometer. The
drug seller told me that I had fever though she didn’t tell
me the type of fever I had, so she told me that I was
going to take tablets and injections and see whether it
would help me; and if it doesn’t, I then go elsewhere’
(Participant 1, FGD with fathers at community 3).
In addition, there were rare reports of drug shops
requesting patients to go for laboratory investigations
before giving treatment, mostly after a patient had earlier
received treatment but not improved. In one drug shop, it
w a sr e p o r t e dt h a ta“strip” was used to diagnose malaria.
From discussions with district health officials and in-
charges of health units, it was acknowledged that diag-
noses of malaria at health facilities were based on the
syndromic approach. At public health facilities with
laboratory services, diagnosis of malaria was constrained
by inadequate laboratory equipment especially micro-
scopes, reagents and other laboratory supplies. The
other major constraint was heavy patient load.
’The main method used to diagnose malaria is by clin-
ical impression, because health workers have a heavy cli-
ent load and can’t send every febrile patient to the
laboratory’ (District Health Official 3).
The syndromic approach to diagnose febrile illness
was promoted by senior health workers. In fact one of
the district health officials noted that this approach is
most appropriate in areas where malaria is endemic.
’Malaria is the commonest cause of fever within our
setting because even under the home based management
of fever, which is recognized by the Ministry of Health, it
is clearly indicated that any fever is malaria unless
proved otherwise’ (District Health Official 3).
Perception of laboratory diagnoses
Although laboratory based microscopic diagnoses was
rarely sought, it was commonly reported that patients
resorted to it after failed presumptive treatment. The
concept of testing was highly appreciated by patients.
This was reflected by high awareness amongst all patient
groups that fevers are not always malaria.
“In fact most of the time I go to a health unit, I like to be
tested because I get to know what the problem is so that
they treat the real cause. Because you may think that it is
malaria, when it is actually another type of fever such as
typhoid. So I like to test blood most of the time” (partici-
pant 2, FGD with community leaders at community 6).
’Malaria is known to share symptoms with other illness,
say cough or a wound. Such illness you may think its malaria
and because there are IMCI meant to treat children, there
they tell us that any person with a high temperature should
be administered with a malaria treatment. But it would be
proper to test blood and be sure that it’sr e a lm a l a r i a ’
(Health worker 5, enrolled midwife at health centre B).
In general, laboratory results were perceived to be
accurate, although trust in results was highly dependent
on the outcome of treatment.
’When they test you and get the treatment and you
become fine, there you become fine, there you believe the
tests. But if you do not become fine, you may doubt the
tests carried out’ (Participant 4, FGD with community
leaders at community 6).
Perceived benefits of RDTs in drug shops
Most community members and drug sellers did not
know about RDTs for malaria diagnosis; but after they
received an explanation, they felt it would be a useful
intervention. Health officials also saw the advantage in
convenience and more accurate treatment,
’If they are trained I think it is ok it will make it like
in the health units and it will make it convenient. They
will not treat blindly. I think the idea is ok’ (District
Health Official 2).
RDTs may increase confidence in treatment
Building on perceptions that laboratory investigations for
malaria facilitate access to effective treatment, respondents
anticipated that RDTs would reduce what was referred to
Table 1 Sample sizes for the study and background characteristics of respondents
Type of Sample Sampling technique Sample
size
Focus Group Discussions (FGDs) Purposively selected; males and females with children aged< 5 years. 10 FGDs
In-depth Interviews (IDIs) Purposively selected; targeting civic leaders, local council officials, drug shops sellers
and health workers
18 KIs
Socio-demographic characteristics
Age range (FGDs-females) (18-52 years)
Age range (FGDs-males) (24-64 years)
Average number of children < 5 years (FGD
participants)
2 (minimum = 1, maximum = 4)
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Page 3 of 8by both recipients and providers as “blind treatment” or
“guess work”. It was perceived that the use of RDTs would
help to establish the cause of illness, which would enable
providers to give effective treatment.
’I welcome RDTs with much interest... Because a patient
can come with fever but claiming to be malaria but when
actually it is flu which has caused that, do you see? But
when you test and the result is negative, you cannot go
ahead to spoil the drug which you could have given another
person with malaria. Do you see? Now you give another
drug which treats the expected illness as you explain to the
patient that ‘you don’t have malaria but the fever is due to
the flu you have this’... and the person gets well, becomes
happy and will have used little money. Because spending
6,000/= on Coartem when not treating malaria, this is a
great loss to the patient!’ (Drug Shop Seller 7).
’Now these people and also we [ourselves] have just
been guessing that it might be malaria but with this test,
it will confirm that it’s either malaria or not’ (Partici-
pant 4, FGD with fathers at community 3).
RDTs may boost confidence and business for drug shops
The presence of RDTs was seen as beneficial to all drug
shop attendants interviewed, who saw that the tests
would improve their reputation and attract patients.
’My business will be moving much better than before
b e c a u s ep e o p l ew i l lb es a y i n gt h a t“Musawo [doctor]
tests your blood first and knows what exactly the pro-
blem is and then prescribes the treatment accordingly"’
(Drug Shop Seller 8).
A direct impact on business was anticipated, through
increased numbers of patients and the probability that
patients testing positive with RDTs being unable to
refuse to purchase anti-malarials. One drug seller
described how he might manipulate the price of RDTs
as he has done for drugs, in response to prices of other
shops as well as once his own reputation was good,
’Now if you treat people well, and talk to people well,
[they will] always say that the health worker treats peo-
ple well, even if she gives you only two tablets, you
become fine. So when I hear such statements, I may
increase the price for the dosage’ (Drug Shop Seller 4).
Another drug seller explained that, rather than char-
ging for the test and drugs separately, he would com-
bine the two costs into a ‘service’ charge,
’It will be possible for them to pay for both the RDT
and the drugs and very easy because when they come I
will be telling them only the amount of the services but
not telling them to pay for the RDT separately from the
drugs’ (Drug Shop Seller 5)
RDTs may save money and time for clients
Besides improving effective treatment for malaria,
drug sellers also thought that RDTs would reduce
unnecessary use of drugs and this would save money for
clients. For example, diseases such as cough, flu and
pneumonia present with high fever like malaria but with
no diagnostics such diseases are treated as malaria, lead-
ing to drug wastage and inappropriate treatment.
Drug sellers perceived RDTs as time saving and lead-
ing to a quick service to clients. When drug sellers do
refer patients for microscopy this only delays treatment
but is also costly as patients have to incur transport and
other costs.
’RDTs will make work easier in that time wasted in
sending a patient for blood testing... all this time will
now be put to serving patients and in one place thus
time saving’ (Drug Shop Seller 5).
RDTs may promote referral
There is no formal system for referral from drug shops
to health facilities. However, respondents in our study
suggested that the use of RDTs might encourage referral
by drug sellers for patients with negative test results,
“RDTs will be very useful because they help to know
what the patient is suffering from, instead of giving drugs
without knowing whether it’s malaria or not. You also
get to know whether you can handle the case or should
refer the patient” (Drug Shop Seller 4).
However, many drug shop sellers interviewed reported
unease about referring, citing experience that patients
were reluctant to be referred due to transport costs,
long waiting times and poor treatment at health centres.
Potential challenges of introducing RDTs in drug shops
RDTs may increase cost of visit
A few community members feared that drug shops
would hike the charges for RDTs because they want to
reap as much profit as they can. Respondents observed
that already many of the patients could not afford to
pay for drugs. There were fears that some patients may
not seek care at drug shops since the cost of RDTs
would increase the overall treatment costs.
’Now, as you know, these health workers who put up
drug shops want money, so when you go there to test
your blood, he will say this, “eh, today the test that has
been at 2,000/= has increased to 5,000/= because this
one is too fast and quick, and I don’tw a n ty o ut os a y
that ‘Musawo [doctor] has increased the price’ but
because am testing you"’ (Participant 4, FGD with
mothers at community 1)
’They will also tell us that eh this thing is expensive
b u ti td e t e c t sm a l a r i as of a s t ,s oi fy o uw a n tt og o
quickly, bring more money and we test you and go now!’
(Participant 5, FGD with mothers at community 1)
District officials were concerned that the additional
costs of RDTs might in fact decrease access to treatment
if patients were deterred by the costs at drug shops,
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are also interested in making profits so any medical
intervention we must weigh how will it affect the flow of
the patients to the drug sellers. Most of our people are
poor... so if it is going to add on the expense the con-
sumption level may be low. So we need to weigh, is it
going to reduce the profits or is it going to deter clients?’
(District Health Official 3)
RDTs may not lead to correct treatment
Another fear expressed was that laboratory tests carried
out in private clinics are not always accurate partly
because private providers are perceived to be money-
minded and by extension may treat patients with RDT
negative results with anti-malarial drugs. In addition,
respondents noted that RDTs only test for malaria
whilst many types of fever were known to exist, with
frequent references to typhoid and yellow fever.
“The patient can present with a fever which may not
be malaria yet the RDT only detects malaria” (a health
worker at Kasawo health centre).
“For me, my only problem with that thing [RDT] is
that, it shows only type of fever. It does not differentiate
between the type of fevers” (Participant 3, FGD with
adult men at community 4).
RDTs may lead to increased client risks
There was fear that RDTs used at drug shops could be
used to test for HIV when people have not consented to
know their status. This may lead some clients to refuse
to be tested, as one drug shop seller described in the
case of sending for microscopy (blood slide) testing,
’Uhm but some do refuse because there are those who
d on o tw a n tt ot e s tf o rH I V / A I D S ,s ow h e ny o ua d v i s e
them to go for a blood slide they mistake this for HIV
testing and such people will never accept to be tested
however much you explain’ (Drug Shop Seller 5).
“There is need for sensitization because in most com-
munities people think that taking of blood means testing
for HIV and some don’t want their HIV status disclosed.
Because of this, some people may shy away from the
drug shops. The truth is that people will ask many ques-
tions about testing with RDTs, but with time, through
sensitization, they will get to understand” (Health
Worker 4, in-charge at Health Centre C).
There was also fear that some drug shops may not
observe good hygiene practices while performing tests
and, therefore, could transmit infections. Some partici-
pants reported that some drug sellers at times give
treatment to clients with dirty hands.
RDTs may not lead to improved referral
There was a concern among community members and
health workers that in spite of the use of RDTs at drug
shops, referral may still not occur, with frequent reports
that drug shop sellers pref e rt oc o n t i n u et ot r e a t
patients than refer, even when seriously ill.
’Once you enter into a drug shop even when the illness
is beyond them, they can’t leave you to go, they make
sure that they get some money out of you’ (Participant 3,
FGD with community leaders at community 9).
’I think it’s because they don’tw a n tt om i s sm o n e y .S o
they try their best to treat the patient, till the patient
sees no sign of improvement and decides to go to a gov-
ernment hospital on his/her own’ (Health Worker 2,
nursing assistant at Health Centre B).
RDTs may be carried out by unqualified staff
This study sought to find out the extent to which differ-
ent actors trusted drug shops. A problem cited by many
health workers and officials as well as community mem-
bers was the lack of trained staff attending at drug
shops.
“The problem we have with drug shops is that some of
the people who run them are not fully qualified. Drug
shops are registered by qualified personnel who in turn
recruit less qualified people to run them on their behalf.”
(District Health Official 1).
“Most of the drug shops here are operated by unquali-
fied people. I have a live example, I went to a drug shop
I had taken my grandchild for treatment they gave us
some tablets which were meant for adults. After giving
the tablets to the child he started vomiting blood” (Parti-
cipant 6, FGD with community leaders at community 6).
None of the drug shops visited had treatment guide-
lines or charts visible as reference materials. Drug sellers
reported that in case they wanted to consult, they rely
on text books, other drug sellers or public health
workers.
Drug sellers were asked how they get information
about new treatment regimes. They said they get infor-
mation either through the radio, when they have visited
public health facilities and from the information sheets
inside drug packets. Through such sources, all drug sell-
ers interacted with during the study knew that Coartem
was the first-line treatment for malaria.
RDTs may suffer from lack of supervision and support from
the district
This study noted inadequate supervision of drug shops
b e c a u s et h e r ew a so n l yo n eo f f i c e ri nt h ed i s t r i c tw h o
supervises drug shops.
“One of the biggest challenges we have in the district is
the supervision of drug shops.W en e e dm o r ep e r s o n n e l
to assist with supervision when RDTs are introduced. For
instance, in the district, there are over 300 drug shops
and you have one person to supervise all of them, it is a
very big task” (District Health Official 3).
Although drug shops were perceived to play an impor-
tant role in treating malaria; this study found that there
was little support from government. For example
numerous workshops were held in the district to refresh
public health workers, excluding drug sellers.
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shop attendants are not invited. Yet most people running
these shops are not trained and there is need to train
them. Another problem is that even when the district dis-
tributes new materials, drug shops are not considered,
like the recent distribution of Uganda Clinical Guide-
lines” (Health Worker 4, in-charge at Health Centre C).
In addition, the study found out that there was poor
record keeping at drug shops, likely a reflection of their
lack of inclusion in the public health system, and with
the result of making it difficult to evaluate practices.
Discussion
The present study shows that introducing RDTs for
malaria diagnosis in drug shops was highly accepted;
although people in this community did not have prior
experience with RDTs. RDTs were perceived to improve
access to effective treatment of malaria, reduce costs
associated with poor treatment, and irrational drug use.
However, it perceived a risk of introducing RDTs due to
increased cost of the test, potentially forcing clients to
seek care elsewhere, a potential delay to referral and a
lack of integration with the public health system which
would not support supervision and evaluation of RDT
use.
Scaling up RDTs for effective treatment of malaria is
now a priory intervention in Uganda. This is initiative is
supported by recent findings indicating that the current
clinical practice in Uganda results in massive over-diag-
n o s i sa c r o s sa l la g eg r o u p sw i t ho v e rt r e a t m e n to f
malaria [17]. Introducing RDTs is also based on studies
elsewhere that have shown that RDTs are highly sensi-
tive in diagnosing malaria [18-20]. In addition, RDTs
have been found to be cost-effective in diagnosing
malaria in out patients in Zambia [21].
The pricing of RDTs in drug shops remains a major
challenge and our results suggest that clients are already
suspicious of profit-centred motives of drug shop atten-
dants which may be increased by introduction of RDTs.
Suggestions of fixed prices, subsidized prices and free-
marked prices were made and each of these needs to be
explored carefully through trials.
Treatment-seeking behaviour and perceptions on
laboratory investigations related to malaria in pregnancy
has previously been documented in the study area and
the stigma related to HIV infection among pregnant
adolescents was found to be a barrier to seeking investi-
gations for malaria [8]. These findings highlight the
need to train drug sellers to explain how the RDTs
work and that they specifically test malaria not HIV. It
is important that whenever clients get in touch with ser-
vice providers, counseling on common illnesses like HIV
infection is done, stigma dispelled and referrals made if
possible. We recommend further research to identify
modalities for integrated counseling on common
illnesses.
In a study of home treatment of febrile children in
Togo, it was found that 83% of children were treated
with an anti-malarial drug at home [9]. In a review of
the treatment-seeking for malaria, [11,12] it was found
that care for most malaria episodes begins with self-
treatment, and that nearly half of all cases were self-
treatment. It has been argued that were people in many
developing countries to cease self-treatment and seek
care at health facilities, these institutions would be
unable to cope with the large influx of patients [10].
This study underscored that one of the apparent fears
to introduce RDTs in drug shops was non-adherence to
the test result and fear that RDTs may test for human
immunodeficiency virus (HIV). Similar findings on poor
diagnosis of malaria have been documented in Tanzania,
where malaria diagnosis did not follow set guidelines
but was influenced by the mind-set of clinicians [22].
Similar fears for HIV testing and poor quality control of
RDTs have also been documented in Tanzania [23,24].
It will be important to train drug shop attendants to
adhere to the RDT result and the importance of this for
effective fever treatment.
Our results show that drug shop attendants have an
uneasy relationship with the public health system as
well as with regulatory authorities. A system for supervi-
sion of these workers is urgently needed if they are to
be included in the fight for improve fever case manage-
ment. Supportive supervision will be important in ensur-
ing tests and results are used correctly in practice. In
the main intervention, the sub-county trainers and the
district assistant drug inspector (DADI) will provide
supervision to drug shops. A social scientist will conduct
a continuous evaluation of this aspect to provide useful
lessons for sustainability of this intervention.
Referral is an important part of this study. By law,
registered drug shops are not permitted to stock anti-
biotics or other “prescription only” medicines. Commer-
cial drug sellers will therefore willbe trained to examine
and refer febrile patients with a negative RDT (i.e. non-
malaria) to the nearest health facility for examination
and treatment by a fully qualified health worker, where
appropriate. Any patient with danger signs and/or a
temperature > 38.5 will be referred to the nearest health
unit as an urgent case. This will be evaluated and les-
sons obtained for future strengthening of referral of
patients.
We found that many drug shop attendants were not
qualified health workers. In order to introduce RDTs
into drug shops, it will be necessary to train the drug
sellers to equip them with skills and knowledge on how
t h eR D T sw o r ks ot h a tt h e yg i v ea p p r o p r i a t ee x p l a n a -
tions to clients. The research team together with the
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useful lessons for improving treatment of malaria in
drug shops.
It will also be necessary for communities to be sensi-
tized about the test, including addressing fears over
hygiene, HIV and costs. The sensitization could utilize
local channels such as social gatherings, churches, politi-
cal meetings and local radio talk shows.
The perceptions and acceptability of RDTs in this pre-
sent study are based on populations’ experience of treat-
ment seeking, including the use of laboratory
investigations of malaria and other illnesses. Although
this is useful in anticipating potential benefits and risks
of the approach, it will also be important to document
how the RDTs are used in practice. Intensive evaluations
are required to document the population’s experiences
with RDTs over time, including how community and
provider perceptions of RDTs interact with the use of
the tests and of anti-malarial drugs as well as wider
potential impacts of RDT implementation in shops.
These should include analysis of impact on individual
and household behaviour, provider behaviour and com-
munity-provider relationships. Furthermore, impacts on
the public health system and on the private sector
should be measured. A detailed framework for this ana-
lysis has been developed by the ACT Consortium [25].
Conclusions
Our study suggests that introducing rapid diagnostic
tests for malaria into drug shops is feasible. Community
members and drug sellers perceived RDTs as a useful
strategy for effective treatment of malaria. However, we
identify a number of challenges that will need to be
addressed if RDTs are to be used effectively, including
guidelines for treatment or referral of RDT negative
patients, regulation or subsidization of the price of
RDTs and a system for training and supervising drug
sellers to use RDTs and adhere to results. These chal-
lenges cannot be underestimated given the important
but neglected position of drug shops in the public health
system in countries such as Uganda.
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